Cambridge, MA, United States of America

Charles Wilson

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Charles Wilson

Introduction

Charles Wilson is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of biomedical engineering. With a total of two patents to his name, Wilson's work focuses on advancing therapeutic techniques through innovative technologies.

Latest Patents

Wilson's latest patents include groundbreaking research on chimeric antigen receptor polypeptides in combination with trans metabolism molecules that modulate the Krebs cycle. This patent discloses genetically engineered hematopoietic cells that express Krebs cycle modulating polypeptides and chimeric receptor polypeptides capable of binding to target antigens. Additionally, he has developed chimeric receptors that enhance antibody-dependent cell-mediated cytotoxicity, which can be utilized in cancer immunotherapy.

Career Highlights

Throughout his career, Wilson has worked with prestigious institutions such as the National University of Singapore and St. Jude Children's Research Hospital. His work has been instrumental in advancing the understanding and application of immune therapies.

Collaborations

Some of Wilson's notable coworkers include Kathleen McGinness and Dario Campana, who have collaborated with him on various projects aimed at improving therapeutic outcomes in patients.

Conclusion

Charles Wilson's innovative contributions to the field of biomedical engineering and his dedication to advancing therapeutic techniques have made a lasting impact. His work continues to inspire future research and development in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…